Post-earnings recap
Reported
Thu, Apr 24, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a strong EPS performance, exceeding expectations by 11.60%. The stock reacted positively, gaining 0.44% in response to the earnings beat. However, the lack of revenue data and forward guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.76 | N/A | +11.60% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized their strategic focus on market expansion.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and expanding our market reach.